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SUMMARY. 11β-hydroxysteroid dehydrogenase (11β-HSD) plays an important part in mediating gluco-
corticoid action, catalyzing the interconversion of corticosterone (B) and dehydrocorticosterone (A) in ro-
dents. The aim of our study is to investigate the effects of (+)-gossypol (G+) on 11β-HSD. Adult ICR mice
were given B and B + (G+) by intraperitoneal injection. The activity of 11β-HSD was evaluated by mea-
suring the ratio of A and B, meanwhile the effects of (+)-gossypol on the conversion rate of B to A was de-
termined with HPLC. Serum A/B levels of the B+(G+) group decreased by 2.42, 7.32, 17.85, 31.39, and
40.02 % compared to the B group at each measured time interval. A/B levels at 1 h for the B + (G+) group
decreased by 43.78, 21.29 and 34.47% in liver, kidney and adrenal glands, respectively, in comparison to
the B group. However, (+)-gossypol had no effect on brain and testis. (+)-Gossypol was an inhibitor of
11β-HSD. 
